LINC00261 Is an Epigenetically Regulated Tumor Suppressor Essential for Activation of the DNA Damage Response

Cancer Research
Shandy ShahabiCrystal N Marconett

Abstract

Lung cancer is the leading cause of cancer-related death in the United States. Long noncoding RNAs (lncRNA) are a class of regulatory molecules whose role in lung carcinogenesis is poorly understood. In this study, we profiled lncRNA expression in lung adenocarcinoma (LUAD) cell lines, compared their expression with that of purified alveolar epithelial type II cells (the purported cell of origin for LUAD), cross-referenced these with lncRNAs altered in the primary human tumors, and interrogated for lncRNAs whose expression correlated with patient survival. We identified LINC00261, a lncRNA with unknown function in LUAD, adjacent to the pioneering transcription factor FOXA2. Loss of LINC00261 was observed in multiple tumor types, including liver, breast, and gastric cancer. Reintroduction of LINC00261 into human LUAD cell lines inhibited cell migration and slowed proliferation by inducing G2-M cell-cycle arrest, while upregulating DNA damage pathway genes and inducing phosphorylation-mediated activation of components of the DNA damage pathway. FOXA2 was able to induce LINC00261 expression, and the entire locus underwent hypermethylation in LUAD, leading to loss of expression. We have thus identified an epigenetically deregulated...Continue Reading

References

Jan 1, 1989·Cancer Chemotherapy and Pharmacology·M M Tomayko, C P Reynolds
Sep 29, 2004·Proceedings of the National Academy of Sciences of the United States of America·Huajing WanJeffrey A Whitsett
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Jun 9, 2006·In Vitro Cellular & Developmental Biology. Animal·Yoko IshikawaYoshinori Masuo
Jun 2, 2010·Nature Reviews. Drug Discovery·Saurabh Aggarwal
May 3, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Akito HataTadashi Ishida
Nov 19, 2011·Cancer Discovery·John R Prensner, Arul M Chinnaiyan
Jan 28, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Liang ChengShaobo Zhang
Mar 23, 2012·Nature Reviews. Cancer·Matthew Vanneman, Glenn Dranoff
Sep 11, 2012·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 15, 2012·Genome Research·Jeong-Sun SeoYoung Tae Kim
Mar 7, 2013·Nature Structural & Molecular Biology·Tim R Mercer, John S Mattick
May 11, 2013·British Journal of Cancer·S W CheethamM E Dinger
Jun 12, 2013·ELife·Maria Gutierrez-ArcelusEmmanouil T Dermitzakis
Jun 27, 2013·World Journal of Gastroenterology : WJG·Wei-Jun CaoZhen-Yu Zhang
Oct 10, 2013·Nature Reviews. Molecular Cell Biology·Sarah Geisler, Jeff Coller
Dec 18, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Antje HascherCarsten Müller-Tidow
Jan 1, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Markus D Siegelin, Alain C Borczuk
Jan 18, 2014·Seminars in Interventional Radiology·Carole A RidgeMichelle S Ginsberg
Feb 5, 2014·Annals of Internal Medicine·Linda L HumphreyChristopher G Slatore
Jun 26, 2014·Journal of Visualized Experiments : JoVE·Calvin R JustusLi V Yang
Jun 30, 2014·Trends in Genetics : TIG·Keith W Vance, Chris P Ponting
Jul 25, 2014·Nature Reviews. Cancer·Zhao ChenKwok-Kin Wong
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 15, 2014·Genome Biology·Nicole M WhiteChristopher A Maher
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 20, 2015·Nature Genetics·Matthew K IyerArul M Chinnaiyan
Nov 9, 2016·Proceedings of the National Academy of Sciences of the United States of America·Angel Diaz-LagaresManel Esteller
Dec 22, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Z K WangG H Dai

❮ Previous
Next ❯

Citations

Nov 7, 2019·Journal of Cellular Biochemistry·Dongli ZhaoGuili Wang
Mar 17, 2020·Journal of Cellular and Molecular Medicine·Shidai JinWen Gao
Jan 1, 2020·Basic and Clinical Andrology·Faruk HadziselimovicMichael B Stadler
Oct 22, 2020·Nature Reviews. Cancer·Gregory J Goodall, Vihandha O Wickramasinghe
Jun 16, 2019·Cancer Research·Veronica Davalos, Manel Esteller
Dec 29, 2020·Cancer Letters·Eunice Eugenia RoblessMarco Falasca
Feb 9, 2021·Frontiers in Genetics·Leonid AdoninNickolai A Barlev
Jan 1, 2020·RNA Biology·Yan HuangXiangting Wang
Mar 27, 2021·Molecular Therapy. Nucleic Acids·Iris EkeMolykutty J Aryankalayil
Mar 31, 2021·Critical Reviews in Oncology/hematology·Tânia R DiasRui Medeiros
Apr 17, 2021·Essays in Biochemistry·Huiwen Yan, Pengcheng Bu
May 24, 2021·Cancer Cell International·Menggang ZhangWenzhi Guo
Jul 6, 2021·Frontiers in Oncology·Shiyi QinShaoqing Ju

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.